Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?

SIMPLE SUMMARY: Systematic biopsy according to the Ginsburg scheme is widely used to complement MRI-targeted biopsy for the diagnosis of prostate cancer. This is the first study to evaluate the distribution of cancerous lesions that were missed by the Ginsburg scheme. We found that significant prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigle, August, Jilg, Cordula A., Kuru, Timur H., Binder, Nadine, Michaelis, Jakob, Grabbert, Markus, Schultze-Seemann, Wolfgang, Miernik, Arkadiusz, Gratzke, Christian, Benndorf, Matthias, Suarez-Ibarrola, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160743/
https://www.ncbi.nlm.nih.gov/pubmed/34065418
http://dx.doi.org/10.3390/cancers13102502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160743/
https://www.ncbi.nlm.nih.gov/pubmed/34065418
http://dx.doi.org/10.3390/cancers13102502

Ejemplares similares